K. Taku

459 total citations
12 papers, 107 citations indexed

About

K. Taku is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, K. Taku has authored 12 papers receiving a total of 107 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in K. Taku's work include Gastric Cancer Management and Outcomes (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Neuroendocrine Tumor Research Advances (3 papers). K. Taku is often cited by papers focused on Gastric Cancer Management and Outcomes (8 papers), Colorectal Cancer Treatments and Studies (6 papers) and Neuroendocrine Tumor Research Advances (3 papers). K. Taku collaborates with scholars based in Japan and Taiwan. K. Taku's co-authors include Nozomu Machida, Akira Fukutomi, Narikazu Boku, Takashi Kojima, Narikazu Boku, Kohichi Yamazaki, Hideharu Tomita, Yusuke Onozawa, Akiko Todaka and Takashi Sakamoto and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Japanese Journal of Clinical Oncology.

In The Last Decade

K. Taku

12 papers receiving 102 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Taku Japan 6 68 48 41 22 12 12 107
Michelle Marcovitz United States 5 82 1.2× 78 1.6× 68 1.7× 31 1.4× 7 0.6× 6 162
Claire Jouffroy-Zeller France 4 102 1.5× 42 0.9× 32 0.8× 26 1.2× 40 3.3× 4 110
Yugo Sawai Japan 7 72 1.1× 78 1.6× 92 2.2× 42 1.9× 12 1.0× 10 147
Sofia Man Israel 5 72 1.1× 77 1.6× 73 1.8× 5 0.2× 12 1.0× 15 137
Vincenzo Panebianco Italy 5 91 1.3× 105 2.2× 68 1.7× 9 0.4× 7 0.6× 8 150
Craig Sommerville United Kingdom 4 73 1.1× 46 1.0× 83 2.0× 26 1.2× 7 0.6× 5 118
Maurizio Ronconi Italy 6 21 0.3× 54 1.1× 72 1.8× 20 0.9× 13 1.1× 15 124
Giovanna Sabella Italy 6 86 1.3× 62 1.3× 59 1.4× 25 1.1× 14 1.2× 23 139

Countries citing papers authored by K. Taku

Since Specialization
Citations

This map shows the geographic impact of K. Taku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Taku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Taku more than expected).

Fields of papers citing papers by K. Taku

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Taku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Taku. The network helps show where K. Taku may publish in the future.

Co-authorship network of co-authors of K. Taku

This figure shows the co-authorship network connecting the top 25 collaborators of K. Taku. A scholar is included among the top collaborators of K. Taku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Taku. K. Taku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Tu, Chia‐Hung, Manabu Muto, Takahiro Horimatsu, et al.. (2010). Submucosal tumor appearance is a useful endoscopic predictor of early primary-site recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma. Diseases of the Esophagus. 24(4). 274–278. 11 indexed citations
3.
Yamazaki, Kohichi, K. Taku, Tomoya Yokota, et al.. (2010). Phase I Study of Docetaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer. Japanese Journal of Clinical Oncology. 40(11). 1014–1020. 3 indexed citations
4.
Todaka, Akiko, Akira Fukutomi, Narikazu Boku, et al.. (2010). S-1 Monotherapy as Second-line Treatment for Advanced Pancreatic Cancer after Gemcitabine Failure. Japanese Journal of Clinical Oncology. 40(6). 567–572. 24 indexed citations
5.
Boku, Narikazu, Yusuke Onozawa, Kohichi Yamazaki, et al.. (2010). Weekly Paclitaxel After Failure of Gemcitabine in Pancreatic Cancer Patients with Malignant Ascites: A Retrospective Study. Japanese Journal of Clinical Oncology. 40(12). 1135–1138. 15 indexed citations
6.
Ishimi, Yoshiko, K. Taku, Keizo Umegaki, & Junichiro Yamauchi. (2009). Systematic review and verification of preventive effects of soy constituents on lifestyle-related diseases: isolated soy isoflavone supplements for postmenopausal bone loss: meta-analysis of randomized controlled trials (Part II).. 12. 11–21. 3 indexed citations
7.
Ono, Akira, Narikazu Boku, Yusuke Onozawa, et al.. (2009). Activity of S-1 in Advanced or Recurrent Gastric Cancer Patients after Failure of Prior Chemotherapy, Including Irinotecan + Cisplatin or Fluorouracil (Except S-1). Japanese Journal of Clinical Oncology. 39(5). 332–335. 4 indexed citations
8.
Yoshino, T., Narikazu Boku, Akira Fukutomi, et al.. (2009). Retrospective Analysis of S-1 Monotherapy in Patients with Metastatic Colorectal Cancer After Failure to Fluoropyrimidine and Irinotecan or to Fluoropyrimidine, Irinotecan and Oxaliplatin. Japanese Journal of Clinical Oncology. 39(5). 315–320. 12 indexed citations
9.
Machida, Nozomu, Narikazu Boku, Yusuke Onozawa, et al.. (2009). 6624 Treatment of metastatic poorly differenciated neuroendocrine carcinoma (PDNEC) with irinotacan plus cisplatin. European Journal of Cancer Supplements. 7(2). 397–397. 2 indexed citations
10.
Yamazaki, K., Takayuki Yoshino, Narikazu Boku, et al.. (2008). Phase I/II study of S-1/LV plus oxaliplatin (SOL) for untreated metastatic colorectal cancer: Preliminary report of the phase I part. Journal of Clinical Oncology. 26(15_suppl). 15101–15101. 2 indexed citations
11.
Machida, Nozomu, et al.. (2008). Impact of Baseline Sum of Longest Diameter in Target Lesions by RECIST on Survival of Patients with Metastatic Colorectal Cancer. Japanese Journal of Clinical Oncology. 38(10). 689–694. 16 indexed citations
12.
Nakashima, Kazuaki, Narikazu Boku, Kentaro Yamazaki, et al.. (2008). Irinotecan Plus Cisplatin Therapy and S-1 Plus Cisplatin Therapy for Advanced or Recurrent Gastric Cancer in a Single Institution. Japanese Journal of Clinical Oncology. 38(12). 810–815. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michelle Marcovitz Breakdown of academic impact, for papers by Claire Jouffroy-Zeller Breakdown of academic impact, for papers by Yugo Sawai Breakdown of academic impact, for papers by Sofia Man Breakdown of academic impact, for papers by Vincenzo Panebianco Breakdown of academic impact, for papers by Craig Sommerville Breakdown of academic impact, for papers by Maurizio Ronconi Breakdown of academic impact, for papers by Giovanna Sabella
Rankless by CCL
2026